Post-Breast Procedure Pain Syndrome Study

February 26, 2015 updated by: Roya Yumul, M.D.,PhD., Cedars-Sinai Medical Center

A Prospective Cohort Study to Evaluate the Incidence and Characteristics of Post-Operative Pain Among Patients Undergoing Various Breast Surgeries

The purpose of this study is to better understand and characterize the pain that some patients experience after undergoing various breast surgeries, including breast biopsy, lumpectomy, mastectomy, mastectomy with reconstruction, cosmetic breast augmentation, and breast reduction.

Study Overview

Status

Withdrawn

Detailed Description

Post-operative breast pain is one of the most common adverse effects after breast surgery procedures. According to previous studies, anywhere from 20-60% of breast surgery patients report mastalgia as an adverse outcome of surgery (1, 2). Although the exact mechanism has not been well defined, the pain is generally neuropathic in nature and described as a burning sensation, electric and shock like, with a stabbing quality (2,3). The large majority of post-operative mastalgia is therefore believed to be secondary to nerve damage, particularly injury to the intercostobrachial nerve, and less commonly the long thoracic, medial and lateral pectoral, and/or the thoracodorsal nerves. Other reported causes of post-operative breast pain include scarring pain, lymphedema, radiation plexopathy, and hematomas (1-5).

Increasing rates of breast surgeries, whether elective, diagnostic, prophylactic, or therapeutic, warrant a more detailed examination of this pain-syndrome, particularly as previous research in the area is rather limited and narrow. A better understanding of the potential mechanisms causing pain, as well as more accurate and current incidence rates, and comparisons of adverse outcomes among the various options available to patients can help guide physicians towards improved clinical practices and patients towards more informed decision-making. Therefore, we designed this prospective cohort study to better understand the underlying mechanisms which may cause post-operative pain after various types of breast surgeries including breast biopsy, lumpectomy, mastectomy, mastectomy with reconstruction, cosmetic augmentation, and breast reduction, as well as to compare and contrast incidence, quality, and distribution of the post-operative pain caused by these various surgical procedures.

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Los Angeles, California, United States, 90048
        • Cedars Sinai Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Patients undergo breast surgery. (breast biopsy, lumpectomy, simple mastectomy,mastectomy with reconstruction, radical mastectomy, radical mastectomy with reconstruction, cosmetic augmentation and breast reduction)

Description

Inclusion Criteria:

  • Patients scheduled to undergo one or more of the breast surgical procedures being studied for this project
  • Willingness and ability to sign an informed consent document
  • No allergies to anesthetic or analgesic medications
  • Female,
  • 18-80 years of age
  • ASA class I-III adult

Exclusion Criteria:

  • Patients with known allergy, hypersensitivity or contraindications to anesthetic or analgesic medications
  • Patients with clinically-significant medical conditions, such as brain, heart, kidney, endocrine, or liver diseases, or history of chronic pain syndrome or neuropathy.
  • Subjects with a history of alcohol or drug abuse within the past 3 months
  • Subjects with a history of pain medication abuse
  • Any other conditions or use of any medication which may interfere with the conduct of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
10% after breast biopsy
Incidence Post-operative pain after breast surgery.
20% after lumpectomy
Incidence Post-operative pain after breast surgery
30% after simple mastectomy
Incidence Post-operative pain after breast surgery
50% after mastectomy with reconstruction
Incidence Post-operative pain after breast surgery
50% after radical mastectomy
Incidence Post-operative pain after breast surgery
50% after radi mastectomy+reconstruction
Incidence Post-operative pain after breast surgery after radical mastectomy with reconstruction
40% after cosmetic augmentation
Incidence Post-operative pain after breast surgery
40% after breast reduction
Incidence Post-operative pain after breast surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Pain using VRS
Time Frame: 6 months
prospective cohort evaluation of patients undergoing various breast surgery procedures, followed for a period of 6 months post-operatively, and assessed for post-operative breast pain.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Opioid consumption obtained from the recorded data
Time Frame: 6 months
Perioperative use of opioid consumption inside hospital (recorded by study staff and data obtained from patient charts) Post discharge use of opioid consumption (data obtained from the follow up questionnaires at 1, 2, or 3, then 7 days and at 6 months after surgery)
6 months
Postoperative nausea and vomiting using a Verbal Rating Scale
Time Frame: 6 months
Outcomes will be measured with follow up questionnaires at 1, 2, or 3, then 7 days and 6 months after surgery
6 months
Return to normal activities of daily living using follow up questionnaires
Time Frame: 6 months
Questionnaires will help evaluate patients recovery and return to normal activities of daily living(including dietary intake, bowel and bladder function, physical activities). Patients will be contacted via mail or e-mail.
6 months
Patient satisfaction using a verbal rating scale from 0 to 100
Time Frame: 6 months
Patients will state their satisfaction level on a scale of 0= Not satisfied to 100= Excellent
6 months
Hospital stay
Time Frame: up to 1 week
Record number of days patients remain in hospital
up to 1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2009

Primary Completion (Anticipated)

June 1, 2014

Study Completion (Anticipated)

June 1, 2014

Study Registration Dates

First Submitted

April 23, 2010

First Submitted That Met QC Criteria

April 30, 2010

First Posted (Estimate)

May 3, 2010

Study Record Updates

Last Update Posted (Estimate)

March 2, 2015

Last Update Submitted That Met QC Criteria

February 26, 2015

Last Verified

February 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00019341

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe